Introduction: We performed 4-year follow-up neuropsychological assessment to investigate cognitive decline and the prognostic abilities from presymptomatic to symptomatic familial frontotemporal dementia (FTD). Methods: Presymptomatic MAPT (n = 15) and GRN mutation carriers (n = 31), and healthy controls (n = 39) underwent neuropsychological assessment every 2 years. Eight mutation carriers (5 MAPT, 3 GRN) became symptomatic. We investigated cognitive decline with multilevel regression modeling; the prognostic performance was assessed with ROC analyses and stepwise logistic regression. Results: MAPT converters declined on language, attention, executive function, social cognition, and memory, and GRN converters declined on attention and exec...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
Background: Frontotemporal dementia is a highly heritable neurodegenerative disorder. In about a thi...
Introduction: We performed 4-year follow-up neuropsychological assessment to investigate cognitive d...
Objective: In this prospective cohort study, we performed a 2-year follow-up study with neuropsychol...
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American A...
Introduction: Trials to test disease-modifying treatments for frontotemporal dementia are eagerly aw...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...
Background and ObjectivesDisease-modifying therapeutic trials for genetic frontotemporal dementia (F...
SummaryBackgroundFrontotemporal dementia is a highly heritable neurodegenerative disorder. In about ...
BACKGROUND: Frontotemporal dementia is a highly heritable neurodegenerative disorder. In about a thi...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
Background: Frontotemporal dementia is a highly heritable neurodegenerative disorder. In about a thi...
Introduction: We performed 4-year follow-up neuropsychological assessment to investigate cognitive d...
Objective: In this prospective cohort study, we performed a 2-year follow-up study with neuropsychol...
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American A...
Introduction: Trials to test disease-modifying treatments for frontotemporal dementia are eagerly aw...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...
Background and ObjectivesDisease-modifying therapeutic trials for genetic frontotemporal dementia (F...
SummaryBackgroundFrontotemporal dementia is a highly heritable neurodegenerative disorder. In about ...
BACKGROUND: Frontotemporal dementia is a highly heritable neurodegenerative disorder. In about a thi...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
Objectives: The clinical heterogeneity of frontotemporal dementia (FTD) complicates identification o...
Background: Frontotemporal dementia is a highly heritable neurodegenerative disorder. In about a thi...